Areerat Hnoonual

Expanding the Clinical Spectrum of DHX30-Related Neurodevelopmental Disorder: A Case Report and a Scoping Review.

Journal: Journal of intellectual disability research : JIDR

Published: April 17, 2026

HLA-B15:21 carrier status is a susceptibility factor of carbamazepine-induced nonimmediate cutaneous adverse reactions in HLA-B15:02-negative patients: A retrospective cohort study.

Journal: British journal of clinical pharmacology

Published: March 11, 2026

Association of decreased CYP2C9 function, HLA-B*40:06, and hemoglobin levels with phenytoin-induced cutaneous adverse reactions in a Southern Thai population.

Journal: Frontiers in pharmacology

Published: March 11, 2026

A 30-Year Experience in Fragile X Syndrome Molecular Diagnosis from a Laboratory in Thailand.

Journal: International journal of molecular sciences

Published: June 28, 2025

Improved approaches to genotyping MAOA-uVNTR polymorphisms with novel allele discovery.

Journal: Scientific reports

Published: March 15, 2025

Clinical Utility and Performance of Methylation-Specific Triplet-Primed PCR for Fragile X Syndrome Diagnosis.

Journal: The Journal of molecular diagnostics : JMD

Published: January 21, 2025

Prevalence and implications of fragile X premutation screening in Thailand.

Journal: Scientific reports

Published: June 28, 2024

Molecular identification of HLA-B75 serotype markers by qPCR: A more inclusive pharmacogenetic approach before carbamazepine prescription.

Journal: Clinical and translational science

Published: February 07, 2024

Clinical and molecular characteristics of FMR1 microdeletion in patient with fragile X syndrome and review of the literature.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: September 18, 2023

Association between 19-bp Insertion/Deletion Polymorphism of Dopamine β-Hydroxylase and Autism Spectrum Disorder in Thai Patients.

Journal: Medicina (Kaunas, Lithuania)

Published: July 21, 2022

Case report: Molecular analysis of a 47,XY,+21/46,XX chimera using SNP microarray and review of literature.

Journal: Frontiers in genetics

Published: October 26, 2021

Screening for FMR1 CGG Repeat Expansion in Thai Patients with Autism Spectrum Disorder.

Journal: BioMed research international

Published: August 30, 2021

Expanding the Clinical Spectrum of DHX30-Related Neurodevelopmental Disorder: A Case Report and a Scoping Review.

Expanding the Clinical Spectrum of DHX30-Related Neurodevelopmental Disorder: A Case Report and a Scoping Review.

HLA-B*15:21 carrier status is a susceptibility factor of carbamazepine-induced nonimmediate cutaneous adverse reactions in HLA-B*15:02-negative patients: A retrospective cohort study.

HLA-B*15:21 carrier status is a susceptibility factor of carbamazepine-induced nonimmediate cutaneous adverse reactions in HLA-B*15:02-negative patients: A retrospective cohort study.

Association of decreased CYP2C9 function, HLA-B*40:06, and hemoglobin levels with phenytoin-induced cutaneous adverse reactions in a Southern Thai population.

Association of decreased CYP2C9 function, HLA-B*40:06, and hemoglobin levels with phenytoin-induced cutaneous adverse reactions in a Southern Thai population.

A 30-Year Experience in Fragile X Syndrome Molecular Diagnosis from a Laboratory in Thailand.

A 30-Year Experience in Fragile X Syndrome Molecular Diagnosis from a Laboratory in Thailand.

Improved approaches to genotyping MAOA-uVNTR polymorphisms with novel allele discovery.

Improved approaches to genotyping MAOA-uVNTR polymorphisms with novel allele discovery.

Clinical Utility and Performance of Methylation-Specific Triplet-Primed PCR for Fragile X Syndrome Diagnosis.

Clinical Utility and Performance of Methylation-Specific Triplet-Primed PCR for Fragile X Syndrome Diagnosis.

Prevalence and implications of fragile X premutation screening in Thailand.

Prevalence and implications of fragile X premutation screening in Thailand.

Molecular identification of HLA-B75 serotype markers by qPCR: A more inclusive pharmacogenetic approach before carbamazepine prescription.

Molecular identification of HLA-B75 serotype markers by qPCR: A more inclusive pharmacogenetic approach before carbamazepine prescription.

Clinical and molecular characteristics of FMR1 microdeletion in patient with fragile X syndrome and review of the literature.

Clinical and molecular characteristics of FMR1 microdeletion in patient with fragile X syndrome and review of the literature.

Association between 19-bp Insertion/Deletion Polymorphism of Dopamine β-Hydroxylase and Autism Spectrum Disorder in Thai Patients.

Association between 19-bp Insertion/Deletion Polymorphism of Dopamine β-Hydroxylase and Autism Spectrum Disorder in Thai Patients.

Case report: Molecular analysis of a 47,XY,+21/46,XX chimera using SNP microarray and review of literature.

Case report: Molecular analysis of a 47,XY,+21/46,XX chimera using SNP microarray and review of literature.

Screening for FMR1 CGG Repeat Expansion in Thai Patients with Autism Spectrum Disorder.

Screening for FMR1 CGG Repeat Expansion in Thai Patients with Autism Spectrum Disorder.

HLA-B15:21 carrier status is a susceptibility factor of carbamazepine-induced nonimmediate cutaneous adverse reactions in HLA-B15:02-negative patients: A retrospective cohort study.

HLA-B15:21 carrier status is a susceptibility factor of carbamazepine-induced nonimmediate cutaneous adverse reactions in HLA-B15:02-negative patients: A retrospective cohort study.